Grantham, Mayo, Van Otterloo & Co (GMO)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $257K | Buy |
+15,337
| New | +$257K | ﹤0.01% | 573 |
|
2024
Q4 | – | Sell |
-18,792
| Closed | -$339K | – | 612 |
|
2024
Q3 | $339K | Sell |
18,792
-2,036,723
| -99% | -$36.7M | ﹤0.01% | 516 |
|
2024
Q2 | $33.4M | Sell |
2,055,515
-377,752
| -16% | -$6.14M | 0.11% | 123 |
|
2024
Q1 | $34.3M | Sell |
2,433,267
-846,794
| -26% | -$11.9M | 0.12% | 119 |
|
2023
Q4 | $34.2M | Sell |
3,280,061
-184,146
| -5% | -$1.92M | 0.15% | 119 |
|
2023
Q3 | $35.3M | Sell |
3,464,207
-85,576
| -2% | -$873K | 0.17% | 110 |
|
2023
Q2 | $26.7M | Buy |
3,549,783
+301,583
| +9% | +$2.27M | 0.12% | 149 |
|
2023
Q1 | $28.7M | Sell |
3,248,200
-502,100
| -13% | -$4.44M | 0.15% | 146 |
|
2022
Q4 | $34.2M | Buy |
3,750,300
+437,400
| +13% | +$3.99M | 0.18% | 119 |
|
2022
Q3 | $26.7M | Sell |
3,312,900
-151,800
| -4% | -$1.23M | 0.15% | 133 |
|
2022
Q2 | $26.1M | Sell |
3,464,700
-11,400
| -0.3% | -$85.7K | 0.14% | 156 |
|
2022
Q1 | $32.6M | Buy |
3,476,100
+700,500
| +25% | +$6.58M | 0.16% | 110 |
|
2021
Q4 | $22.2M | Sell |
2,775,600
-30,100
| -1% | -$241K | 0.11% | 158 |
|
2021
Q3 | $27.3M | Buy |
2,805,700
+252,800
| +10% | +$2.46M | 0.14% | 130 |
|
2021
Q2 | $25.3M | Buy |
2,552,900
+559,000
| +28% | +$5.53M | 0.13% | 136 |
|
2021
Q1 | $23M | Buy |
1,993,900
+178,300
| +10% | +$2.06M | 0.13% | 131 |
|
2020
Q4 | $17.5M | Buy |
+1,815,600
| New | +$17.5M | 0.11% | 130 |
|
2019
Q1 | – | Sell |
-15,000
| Closed | -$231K | – | 739 |
|
2018
Q4 | $231K | Buy |
+15,000
| New | +$231K | ﹤0.01% | 495 |
|
2018
Q3 | – | Sell |
-36,900
| Closed | -$897K | – | 573 |
|
2018
Q2 | $897K | Buy |
+36,900
| New | +$897K | 0.01% | 363 |
|
2017
Q1 | – | Sell |
-14,950
| Closed | -$542K | – | 613 |
|
2016
Q4 | $542K | Sell |
14,950
-321,750
| -96% | -$11.7M | ﹤0.01% | 376 |
|
2016
Q3 | $15.5M | Buy |
336,700
+49,400
| +17% | +$2.27M | 0.07% | 174 |
|
2016
Q2 | $14.4M | Buy |
+287,300
| New | +$14.4M | 0.06% | 197 |
|
2014
Q3 | – | Sell |
-11,400
| Closed | -$598K | – | 476 |
|
2014
Q2 | $598K | Sell |
11,400
-2,000
| -15% | -$105K | ﹤0.01% | 433 |
|
2014
Q1 | $708K | Buy |
+13,400
| New | +$708K | ﹤0.01% | 496 |
|